Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

63/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

1871.20

19-Apr-2024

Open
High
Low
Previous Close

1878.15
1878.20
1854.00
1888.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

49219
919.36
2524.00
1227.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

31,659.45
60.51
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

30,568.14
1.71%
20.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
0.78
3.59

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
6.01
6.10

PAT CAGR (%)

10 Years
5 Years
3 Years

-
6.41
28.37

P:E (Median)

8 Years
5 Years
3 Years

60.90
51.98
42.61

P:BV (Average)

8 Years
5 Years
3 Years

14.00
14.98
15.84

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.49
29.70
27.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 804.98 799.11 0.73% 953.38 905.61 5.27% 738.02 729.46 1.17% 782.16 791.92 -1.23%
Expenses 587.47 571.31 2.83% 666.80 648.69 2.79% 596.77 581.53 2.62% 615.40 618.50 -0.50%
EBITDA 217.51 227.80 -4.52% 286.58 256.92 11.54% 141.25 147.93 -4.52% 166.76 173.42 -3.84%
EBIDTM 27.02% 28.51% 30.06% 28.37% 19.14% 20.28% 21.32% 21.90%
Other Income 28.34 23.60 20.08% 28.47 22.16 28.47% 36.80 27.79 32.42% 27.97 18.94 47.68%
Interest 0.32 0.09 255.56% 0.43 0.39 10.26% 0.28 0.68 -58.82% 0.65 0.27 140.74%
Depreciation 17.11 16.41 4.27% 18.11 16.36 10.70% 16.36 15.82 3.41% 17.18 15.35 11.92%
PBT 65.11 223.53 -70.87% 296.51 262.33 13.03% 178.71 159.22 12.24% 187.30 206.24 -9.18%
Tax 19.62 59.50 -67.03% 80.97 68.77 17.74% 48.13 43.59 10.42% 55.82 262.11 -78.70%
PAT 45.49 164.03 -72.27% 215.54 193.56 11.36% 130.58 115.63 12.93% 131.48 -55.87 -
PATM 5.65% 20.53% 22.61% 21.37% 17.69% 15.85% 16.81% -7.05%
EPS 2.69 9.68 -72.21% 12.72 11.43 11.29% 7.71 6.83 12.88% 7.76 -3.30 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 805.26 802.30 0.37% 956.99 916.87 4.38% 761.66 745.10 2.22% 787.45 809.63 -2.74%
Expenses 587.20 573.60 2.37% 667.50 659.94 1.15% 617.78 596.18 3.62% 617.71 634.41 -2.63%
EBITDA 218.06 228.70 -4.65% 289.49 256.93 12.67% 143.88 148.92 -3.38% 169.74 175.22 -3.13%
EBIDTM 27.08% 28.51% 30.25% 28.02% 18.89% 19.99% 21.56% 21.64%
Other Income 28.11 23.42 20.03% 28.21 21.97 28.40% 36.44 27.61 31.98% 27.66 18.76 47.44%
Interest 0.32 0.09 255.56% 0.43 0.39 10.26% 0.28 0.68 -58.82% 0.65 0.28 132.14%
Depreciation 17.11 16.41 4.27% 18.11 16.36 10.70% 16.36 15.82 3.41% 17.18 15.35 11.92%
PBT 65.43 224.25 -70.82% 299.16 262.15 14.12% 180.98 160.03 13.09% 189.97 207.85 -8.60%
Tax 19.71 59.69 -66.98% 81.65 68.73 18.80% 48.73 43.80 11.26% 56.54 262.51 -78.46%
PAT 45.72 164.56 -72.22% 217.51 193.42 12.45% 132.25 116.23 13.78% 133.43 -54.66 -
PATM 5.68% 20.51% 22.73% 21.10% 17.36% 15.60% 16.94% -6.75%
EPS 2.70 9.71 -72.19% 12.84 11.42 12.43% 7.81 7.04 10.94% 7.88 71.96 -89.05%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Net Sales 3,278.54 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 2,591.16 Net Sales Growth 1.63% -0.04% 10.17% -9.43% 3.07% 8.94% -1.08% 2.72% -15.53% 29.13% Cost Of Goods Sold 1,282.13 1,250.03 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 1,166.02 Gross Profit 1,996.41 1,966.32 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 1,425.14 GP Margin 60.89% 61.14% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% 55.00% Total Expenditure 2,466.44 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 2,114.09 Power & Fuel Cost - 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 % Of Sales - 0.92% 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.92% Employee Cost - 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 362.05 % Of Sales - 18.50% 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% 13.97% Manufacturing Exp. - 99.05 120.14 110.59 107.88 115.19 110.55 108.26 117.67 365.85 127.72 % Of Sales - 3.08% 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% 4.93% General & Admin Exp. - 189.33 143.99 117.27 164.31 178.51 203.43 194.72 154.34 177.98 134.79 % Of Sales - 5.89% 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% 5.20% Selling & Distn. Exp. - 180.97 199.59 124.73 212.36 202.81 154.38 178.88 164.26 222.32 186.27 % Of Sales - 5.63% 6.20% 4.27% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% 7.19% Miscellaneous Exp. - 72.95 64.17 78.51 111.89 106.88 104.29 96.61 125.19 164.01 186.27 % Of Sales - 2.27% 1.99% 2.69% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% 4.38% EBITDA 812.10 799.42 755.83 597.78 658.45 606.48 508.44 419.94 476.75 568.79 477.07 EBITDA Margin 24.77% 24.85% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% 18.41% Other Income 121.58 101.51 76.22 110.19 77.56 101.48 53.52 72.01 122.25 257.53 246.31 Interest 1.68 1.81 1.99 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 Depreciation 68.76 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 19.88 PBT 727.63 833.36 761.87 625.83 646.99 658.82 523.78 465.35 573.63 800.50 703.17 Tax 204.54 227.69 396.87 166.54 212.45 238.35 189.60 174.30 201.41 276.98 227.44 Tax Rate 28.11% 27.35% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% 31.19% PAT 523.09 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 501.88 PAT before Minority Interest 523.09 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 501.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.95% 18.80% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% 19.37% PAT Growth 25.34% 60.58% 31.35% 160.51% -74.13% 20.84% 4.52% -10.08% -20.59% -6.02% EPS 30.88 35.70 22.23 16.92 6.50 25.11 20.78 19.88 22.11 27.84 29.63

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Net Sales 3,311.36 3,251.72 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 2,607.70 Net Sales Growth 1.14% -0.80% 12.05% -9.27% 3.08% 8.94% -1.27% 2.49% -15.61% 28.96% Cost Of Goods Sold 1,312.19 1,284.88 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 1,171.68 Gross Profit 1,999.17 1,966.85 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 1,436.02 GP Margin 60.37% 60.49% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% 55.07% Total Expenditure 2,490.19 2,447.44 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 2,124.49 Power & Fuel Cost - 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 % Of Sales - 0.91% 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.91% Employee Cost - 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 362.05 % Of Sales - 18.30% 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% 13.88% Manufacturing Exp. - 99.05 120.14 110.59 107.89 115.55 110.55 108.26 118.09 367.24 127.78 % Of Sales - 3.05% 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% 4.90% General & Admin Exp. - 189.33 144.08 117.31 164.51 178.60 204.45 195.08 154.85 178.21 135.34 % Of Sales - 5.82% 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% 5.19% Selling & Distn. Exp. - 180.97 199.59 124.73 212.36 202.81 154.38 178.91 164.47 222.31 186.23 % Of Sales - 5.57% 6.09% 4.26% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% 7.14% Miscellaneous Exp. - 68.62 58.09 75.74 112.58 107.20 105.12 98.67 127.99 168.72 186.23 % Of Sales - 2.11% 1.77% 2.59% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% 4.51% EBITDA 821.17 804.28 761.88 598.14 657.25 600.80 505.79 418.98 478.27 574.58 483.21 EBITDA Margin 24.80% 24.73% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% 18.53% Other Income 120.42 100.66 75.78 110.58 79.01 102.32 54.54 73.07 123.18 258.80 222.30 Interest 1.68 1.81 2.00 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 Depreciation 68.76 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 19.88 PBT 735.54 837.37 767.47 626.59 647.25 653.97 522.17 465.46 576.08 807.56 685.30 Tax 206.63 228.76 398.28 166.72 212.55 237.28 189.24 174.37 202.25 279.27 229.78 Tax Rate 28.09% 27.35% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% 32.30% PAT 528.91 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 481.67 PAT before Minority Interest 528.91 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 481.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.97% 18.69% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% 18.47% PAT Growth 26.07% 59.58% 32.55% 208.23% -79.07% 26.99% 4.13% -10.46% -21.05% -1.09% EPS 31.22 35.87 22.48 16.96 5.50 26.29 20.70 19.88 22.20 28.12 28.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Shareholder's Funds 1,753.00 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 2,017.19 Share Capital 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,585.27 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 1,932.49 Non-Current Liabilities 124.49 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 157.51 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 Long Term Provisions 253.55 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 241.04 Current Liabilities 1,317.03 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 883.07 Trade Payables 418.56 555.45 447.99 354.19 402.96 502.53 275.92 323.09 305.89 278.01 Other Current Liabilities 184.47 503.54 433.09 205.84 802.59 842.33 391.18 203.59 131.56 86.22 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 713.99 615.36 438.35 442.04 1,595.07 1,600.30 211.22 48.18 668.42 518.83 Total Liabilities 3,194.52 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 3,057.77 Net Block 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.06 100.07 Gross Block 649.79 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 319.19 299.08 Accumulated Depreciation 320.89 262.20 215.09 695.76 129.06 83.08 46.38 24.32 196.13 199.01 Non Current Assets 727.80 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 456.03 Capital Work in Progress 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 Non Current Investment 24.49 24.49 25.82 25.97 26.17 49.43 52.99 53.63 47.67 47.67 Long Term Loans & Adv. 347.22 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 232.87 Other Non Current Assets 5.84 5.44 7.03 7.17 7.84 4.75 6.47 0.06 11.12 13.55 Current Assets 2,466.72 3,670.60 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 2,601.73 Current Investments 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 Inventories 437.70 512.71 523.34 483.03 486.49 500.18 425.48 521.66 368.86 342.40 Sundry Debtors 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 Cash & Bank 1,150.73 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 2,027.14 Other Current Assets 167.62 79.55 218.22 48.43 1,578.61 1,585.33 332.19 121.90 197.99 125.80 Short Term Loans & Adv. 12.22 28.39 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 68.16 Net Current Assets 1,149.69 1,996.24 851.90 754.71 540.31 567.01 932.39 1,572.94 1,459.32 1,718.67 Total Assets 3,194.52 4,509.70 2,995.41 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48 3,057.76

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Shareholder's Funds 1,741.27 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 1,989.73 Share Capital 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,573.54 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 1,905.03 Non-Current Liabilities 125.40 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 158.59 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 Long Term Provisions 254.80 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 242.29 Current Liabilities 1,326.37 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 888.91 Trade Payables 427.79 579.33 466.13 357.06 405.81 505.86 278.93 327.74 308.04 285.63 Other Current Liabilities 184.59 503.74 450.11 222.85 802.71 842.35 390.47 202.82 130.09 84.13 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 713.99 615.36 438.35 442.04 1,595.54 1,600.77 211.69 253.08 668.42 519.15 Total Liabilities 3,193.04 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 3,037.23 Net Block 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.08 100.09 Gross Block 649.79 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 363.34 343.22 Accumulated Depreciation 320.89 262.20 215.09 695.76 129.06 83.08 46.38 24.32 240.26 243.13 Non Current Assets 698.77 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 413.30 Capital Work in Progress 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 Non Current Investment 0.00 0.00 1.35 1.49 1.69 1.84 5.40 6.04 0.06 0.06 Long Term Loans & Adv. 342.64 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 237.73 Other Non Current Assets 5.86 5.45 7.05 7.17 7.84 4.75 6.47 0.06 11.13 13.55 Current Assets 2,494.26 3,707.92 2,202.64 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 2,623.94 Current Investments 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 Inventories 459.97 534.70 546.70 483.03 486.49 500.18 425.80 525.87 375.58 346.97 Sundry Debtors 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 Cash & Bank 1,155.93 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 2,041.58 Other Current Assets 167.70 89.49 225.89 48.58 1,580.88 1,591.97 338.90 333.82 200.47 128.99 Short Term Loans & Adv. 12.22 28.40 56.48 60.27 1,468.58 1,513.25 232.20 310.58 112.04 71.19 Net Current Assets 1,167.89 2,009.49 848.06 752.93 555.14 586.54 954.01 1,594.52 1,480.43 1,735.03 Total Assets 3,193.03 4,520.02 3,011.52 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56 3,037.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Cash From Operating Activity 487.94 819.79 594.87 490.97 411.18 474.77 232.28 138.27 340.88 267.42 PBT 837.49 2,470.04 722.33 646.99 658.82 523.78 465.35 573.63 800.50 703.17 Adjustment -40.86 -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 -180.38 Changes in Working Capital -39.02 134.89 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 1.66 Cash after chg. in Working capital 757.61 968.00 760.11 704.78 620.71 676.33 390.46 353.51 597.94 524.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -260.57 -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 -242.05 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -9.11 -36.06 -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 -14.97 Cash From Investing Activity 805.19 -419.66 407.57 -63.10 -154.44 -107.01 303.08 499.09 177.62 197.98 Net Fixed Assets -47.95 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 Net Investments -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 Others 1,005.84 -47.11 -551.19 -52.52 55.20 313.67 710.96 566.67 241.09 198.17 Cash from Financing Activity -1,544.18 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -490.08 Net Cash Inflow / Outflow -251.05 -124.11 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 -24.68 Opening Cash & Equivalents 280.79 404.90 98.03 97.78 199.40 138.27 113.68 114.66 93.50 137.07 Closing Cash & Equivalent 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 115.01 112.39

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Cash From Operating Activity 484.23 810.75 577.91 490.50 409.49 472.80 234.37 138.90 337.64 281.31 PBT 841.49 2,475.65 723.10 647.25 653.97 522.17 465.46 576.08 807.56 685.30 Adjustment -40.00 -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 -156.37 Changes in Working Capital -45.75 119.87 45.75 44.07 -4.19 164.56 -26.69 -124.41 -36.90 11.45 Cash after chg. in Working capital 755.75 959.04 743.20 704.49 618.41 674.55 392.29 355.67 597.00 540.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -262.42 -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 -244.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -9.11 -36.06 -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 0.00 Cash From Investing Activity 807.85 -405.51 418.03 -56.84 -153.45 -104.19 300.64 499.02 180.01 188.98 Net Fixed Assets -47.95 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 Net Investments -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 Others 1,008.50 -32.96 -540.73 -46.26 56.19 316.49 708.52 566.60 243.48 189.17 Cash from Financing Activity -1,543.32 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -494.14 Net Cash Inflow / Outflow -251.25 -119.00 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 -23.85 Opening Cash & Equivalents 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.30 94.93 137.67 Closing Cash & Equivalent 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.59 113.82

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Book Value (Rs.) 103.58 158.06 88.37 108.62 126.47 122.78 119.72 130.14 109.30 119.07 ROA 15.70% 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% 16.56% ROE 27.29% 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% 24.92% ROCE 37.66% 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% 36.16% Fixed Asset Turnover 5.69 5.93 3.04 3.21 6.48 8.22 11.35 10.32 11.16 9.33 Receivable days 20.54 21.73 18.45 12.47 15.60 20.03 18.12 14.65 10.40 14.54 Inventory Days 49.10 53.51 58.87 54.87 57.56 58.34 57.72 57.50 37.61 42.77 Payable days 142.20 141.33 117.18 57.46 72.90 65.55 50.91 53.40 43.13 48.42 Cash Conversion Cycle -72.56 -66.09 -39.85 9.88 0.26 12.81 24.94 18.76 4.88 8.89 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 460.68 389.70 129.34 51.90 1198.38 2865.01 2045.32 1368.05 1597.21 2205.05

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Book Value (Rs.) 102.89 157.19 87.26 107.47 126.31 121.44 118.46 128.88 107.96 117.45 ROA 15.76% 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% 15.95% ROE 27.58% 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% 24.10% ROCE 38.06% 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% 35.54% Fixed Asset Turnover 5.75 6.03 3.04 3.21 6.48 8.21 11.38 9.59 9.82 8.13 Receivable days 20.34 21.37 18.42 12.47 15.60 20.03 18.09 14.59 10.35 14.45 Inventory Days 50.87 54.91 60.14 54.88 57.56 58.36 57.89 57.97 38.01 43.02 Payable days 143.05 140.69 119.53 57.89 73.24 66.07 51.56 53.81 43.72 49.18 Cash Conversion Cycle -71.84 -64.41 -40.97 9.45 -0.07 12.32 24.42 18.75 4.64 8.28 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 462.54 391.29 129.56 49.26 1232.59 2856.45 2045.74 1373.88 1612.26 2146.51

Top Investors:

lici asm non par

aditya birla sun life trustee private limited a/c

investor education and protection fund (iepf)

Annual Reports:

News Update:

Glaxosmithkline Phar - Quarterly Results
12th Feb 2024, 16:55 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback